Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Lenz Therapeutics Inc (LENZ)

143 + Investors. Track Smart Money conviction in LENZ. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -17
Streak
2Q ▼
Buyers last Q
53%

Smart Money Signals — LENZ

Based on 144 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their LENZ positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 88% of 3.0Y peak

88% of all-time peak
144 funds currently hold this stock — 88% of the 3.0-year high of 164 funds (reached 2025 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
🚀

Fast accumulation — +36% more funds vs a year ago

fund count last 6Q
+38 new funds entered over the past year (+36% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟡

Slight buying edge — 53% buying

91 buying80 selling
Last quarter: 91 funds bought or added vs 80 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-18 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 27 → 54 → 51 → 33. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔄

Mostly new holders — 44% entered in last year

■ 22% conviction (2yr+) ■ 33% medium ■ 44% new
Only 32 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💎

Buying through price weakness — shares -5%, value -45%

Value
-44%
Shares
-5%
Last quarter: funds added -5% more shares while total portfolio value only changed -45%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~33 new funds/quarter

26 → 27 → 54 → 51 → 33 new funds/Q
New funds entering each quarter: 27 → 54 → 51 → 33. Consistent flow of new institutional buyers without clear acceleration or slowdown.
📊

Mixed cohorts — 5% veterans, 51% new entrants

■ 5% veterans ■ 45% 1-2yr ■ 51% new
Of 148 current holders: 7 (5%) held 2+ years, 66 held 1–2 years, 75 (51%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.
✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds
37 of 142 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.9
out of 10
Low Exit Risk
Exit risk score 3.9/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — LENZ

In 2026 Q1, 91 hedge funds were net buyers of LENZ (33 opened a new position, 58 added to an existing one), while 80 reduced or exited (30 trimmed, 50 sold completely) — a 53% buyer ratio, indicating a slight buying edge. Net selling has persisted for two consecutive quarters. 35% of total institutional value in LENZ is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -17 funds (more exits than new entries). Total institutional holders: 144.

Hedge Fund Ownership: LENZ

How many hedge funds hold LENZ — quarterly history vs. share price
Quarterly hedge fund ownership of LENZ vs. share price

Market Analysis: LENZ

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: LENZ

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Lenz Therapeutics Inc (LENZ) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much LENZ has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 47d ago
LENZ
-16.7%
XLV
+5.5%

LENZ outperformed XLV by -22.2% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 2d ago
LENZ
+0.0%
XLV
+0.0%

Since the filing became public, LENZ outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

16 top-rated funds 0 high-conviction
Consensus
5.3
/ 10
breadth
×
Elite
0.7
/ 10
conviction
Hedge Fund Positioning: LENZ
2026 Q2 Stats Unlock in 3 days 143 + Investors

Track Smart Money conviction in LENZ. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 143 161 -11.18%
13F Shares 34M 35M -5.38%
Total Value $306M $551M -44.54%
New Positions 32 51 -19
Increased Positions 56 53 +3
Closed Positions 50 54 -4
Reduced Positions 29 33 -4
Total Calls 3 3 -
Total Puts 3 4 -25.0%
PUT/CALL Ratio 1.0 1.33 Neutral

Statistics: LENZ

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

143 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LENZ. Verified SEC 13F-HR filings.

QUARTER:
2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 LENZ holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 72 Investment Holdings, LLC 11.57% 1,017,751 $5.8M
2 Versant Venture Management, LLC 9.28% 2,656,888 $15.1M
3 Blue Owl Capital Holdings LP 0.65% 756,722 $4.3M
4 Alpha Wave Global, LP 0.33% 3,612,211 $20.5M
5 Ra Capital Management, L.P. 0.21% 4,178,823 $23.7M
6 Tang Capital Management LLC 0.12% 451,114 $2.6M
7 Scoggin Management LP 0.11% 175,000 $994K
8 Verdad Advisers, LP 0.09% 15,900 $90K
9 Rock Springs Capital Management LP 0.07% 257,460 $1.5M
10 Discovery Capital Management, LLC / Ct 0.06% 241,300 $1.4M
11 Occudo Quantitative Strategies LP 0.04% 146,376 $831K
12 Mangrove Partners IM, LLC 0.04% 96,749 $550K
13 Aigen Investment Management, LP 0.03% 20,055 $114K
14 Kelleher Financial Advisors 0.03% 34,046 $193K
15 Affinity Asset Advisors, LLC 0.03% 100,000 $568K
16 Trexquant Investment LP 0.02% 497,526 $2.8M
17 Atom Investors LP 0.02% 31,826 $181K
18 Abel Hall, LLC 0.02% 15,876 $90K
19 Susquehanna Portfolio Strategies, LLC 0.01% 154,053 $875K
20 Aberdeen Group plc 0.01% 1,547,883 $8.8M
21 Squarepoint Ops LLC 0.01% 1,747,096 $9.9M
22 XTX Topco Ltd 0.01% 130,625 $742K
23 Y-Intercept (Hong Kong) Ltd 0.01% 70,728 $402K
24 Axq Capital, LP 0.01% 12,744 $72K
25 Prelude Capital Management, LLC 0.01% 17,685 $100K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Lenz Therapeutics Inc (LENZ)

What does the Smart Money Trend signal show for LENZ?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their LENZ positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for LENZ?

Slight buying edge — 53% buying: Last quarter: 91 funds bought or added vs 80 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for LENZ holders?

Strong quality — 35% AUM from major funds: 37 of 142 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held LENZ?

Mostly new holders — 44% entered in last year: Only 32 funds (22%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Lenz Therapeutics Inc (LENZ) following the 2026 Q2 hedge fund 13F filings?

As of today, LENZ has moved +0.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (June 30, 2026), LENZ has gained -16.7% vs +5.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →